Source: Annual Congress 2006 - Biological features, lung function and treatment of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. S. Hacievliyagil, H. Gunen, L. C. Mutlu, G. Gülbas, O. Yetkin, H. Atmaca (Malatya, Turkey). The role of serum copper and zinc levels and copper/zinc ratio in lung cancer. Eur Respir J 2006; 28: Suppl. 50, 4420

Member's Comments

No comment yet.

Related content which might interest you: The contribution of serum ferritin, iron, iron binding capacity and bronchoalveolar lavage ferritin levels in differential diagnosis of lung cancer from benign pulmonary diseases Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 The role of iron and transferrin serum levels in lung cancer patients - a single institution experience Source: Eur Respir J 2005; 26: Suppl. 49, 330s Year: 2005 Evaluation of serum levels of Sirtuin-1 in lung cancer patients Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Elevated serum levels of oxidative stress biomarkers in patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Analysis of zinc,copper and copper /zinc values in serum and hair of new and chronic cases of pulmonary parenchymal tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003 Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Low levels of heme oxygenase-1 in induced sputum of lung cancer patients as a marker of defective cytoprotection Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 The importance of erythrocyte superoxide dismutase activity and serum vitamin C concentration assay in children with asthma Source: Annual Congress 2006 - Aspects of childhood asthma Year: 2006 Clinical significance of serum osteopontin levels in lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 The study on the association of serum C-reactive protein level with the risk of lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma Source: Eur Respir J 2007; 29: 273-278 Year: 2007 Increased levels of plasmatic dopamine in human small cell lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Evaluation of oxidant-antioxidant status in different stages of COPD: determination of serum paraoxonase1 and malonyldialdehyde levels Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Plasma total antioxidant status and erythrocyte antioxidant enzyme activities in lung cancer in Turkey Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Serum haem oxygenase-1 as marker of lung function in patients with chronic silicosis Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease Year: 2009 IGF-I and IGFBP-3 concentrations in the blood serum and lung cancer risk Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005 Experimental emphysema: effect of tocopherol on serum lipid profile and iron content in lung tissue Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005 Serum hepcidin and iron are associated with non-small cell lung cancer stage Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016